한국어
English
日本語
中文(简体)
Bredinin Tablet 25 mg (Mizoribine)
25mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Mizoribine is an ingredient that regulates autoimmune diseases and transplant rejection reactions through its immunosuppressive action.
MFDS ingredient code M086418
Mizoribine is classified as an immunosuppressant, used to inhibit excessive reactions of the immune system. It is primarily used in the treatment of autoimmune diseases and in the prevention of rejection reactions after organ transplantation. This ingredient regulates immune responses by inhibiting the proliferation of immune cells.
Mizoribine reduces the activity of immune cells by interfering with the nucleic acid synthesis required for immune cell proliferation. This prevents the immune system from becoming overly activated, thereby alleviating autoimmune diseases or transplant rejection reactions.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other immunosuppressants, Mizoribine primarily acts through the inhibition of nucleic acid synthesis and has a relatively mild side effect profile. Additionally, it is advantageous in that it selectively acts on specific immune cells to regulate systemic immunosuppressive effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
